Cargando…
Raloxifene for older women: a review of the literature
Raloxifene is a non-steroidal selective estrogen-receptor modulator (SERM) which is used for prevention and treatment of postmenopausal osteoporosis. Raloxifene decreases the incidence of vertebral fractures by 30%–50% in postmenopausal women with osteoporosis but has not been shown to decrease the...
Autor principal: | Hansdóttir, Helga |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2544368/ https://www.ncbi.nlm.nih.gov/pubmed/18488877 |
Ejemplares similares
-
Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
por: Fujiwara, Saeko, et al.
Publicado: (2014) -
The Beneficial and Adverse Effects of Raloxifene in Menopausal Women: A Mini Review
por: Khorsand, Imaneh, et al.
Publicado: (2018) -
Effect of Raloxifene Treatment on Osteocyte Apoptosis in Postmenopausal Women
por: van Essen, Huib W., et al.
Publicado: (2007) -
Raloxifene May Have Further Benefits in Women on Hemodialysis
por: Worsley, Roisin, et al.
Publicado: (2012) -
Raloxifene in Hemodialysis Patients
por: Keller, Frieder
Publicado: (2012)